Spironolactone Tablets, USP, 25 mg, 100-count bottle, Rx only, Mfg. by: Frontida BioPharm, Inc., 1100 Orthodox St, Philadelphia, PA 19124, Dist. by: Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512, NDC 53489-143-01
Published August 13, 2025 · Recall initiated: August 5, 2025
Summary
FDA records drug Class II recall D-0574-2025, published August 13, 2025 and initiated August 5, 2025. Recalling firm: SUN PHARMACEUTICAL INDUSTRIES INC; Status: Ongoing; Reported quantity: 11,328 bottles; Lot: Lot # P3314, Exp 11/30/2026. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Presence of foreign substance: identified as aluminum.
What to do
Voluntary: Firm initiated · Letter
Get an email if SPIRONOLACTONE has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- SPIRONOLACTONE
- Manufacturer
- SUN PHARMACEUTICAL INDUSTRIES INC
- Distributor
- USA Nationwide
- UPC
- 0353489143011
- Lot
- Lot # P3314, Exp 11/30/2026
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDARECOMBINATE, [Antihemophilic Factor (Recombinant)], 5 mL vials, Rx Only, Takeda Pharmaceuticals USA,August 13, 2025
- FDABrand Name: Queen Bee Gardens Whipped Honey Raspberry. Intended use: spread. Item is shelf stable. PackagingAugust 13, 2025
- FDAXolair (omalizumab injection), 75 mg/0.5 ml, Rx only, Genentech, Inc., South San Francisco, CA 94080, NDCAugust 13, 2025
- FDABrand Name: Queen Bee Gardens Whipped Honey Pure. Intended use: spread. Item is shelf stable. Packaging type:August 13, 2025
- FDAXolair (omalizumab injection), 150 mg/ml, 1 auto-injector, Rx only, Genentech, Inc, South San Francisco, CAAugust 13, 2025
- FDABrand Name: Queen Bee Gardens Whipped Honey Huckleberry Intended use: spread. Item is shelf stable. PackagingAugust 13, 2025
Questions about this recall
Was Spironolactone Tablets, USP, 25 mg, 100-count bottle, Rx only, Mfg. by: Frontida BioPharm, Inc., 1100 Orthodox St, Philadelphia, PA 19124, Dist. by: Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512, NDC 53489-143-01 recalled?
Yes. FDA published recall D-0574-2025 on August 13, 2025. Reported hazard: Presence of foreign substance: identified as aluminum.
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: SPIRONOLACTONE. UPC: 0353489143011.